Show simple item record

contributor authorArjunon, Sivakkumar
contributor authorArdana, Pablo Hidalgo
contributor authorSaikrishnan, Neelakantan
contributor authorMadhani, Shalv
contributor authorFoster, Brent
contributor authorGlezer, Ari
contributor authorYoganathan, Ajit P.
date accessioned2017-05-09T01:15:07Z
date available2017-05-09T01:15:07Z
date issued2015
identifier issn0148-0731
identifier otherbio_137_04_045001.pdf
identifier urihttp://yetl.yabesh.ir/yetl/handle/yetl/157106
description abstractDue to expensive nature of clinical trials, implantable cardiac devices should first be extensively characterized in vitro. Prosthetic heart valves (PHVs), an important class of these devices, have been shown to be associated with thromboembolic complications. Although various in vitro systems have been designed to quantify bloodcell damage and platelet activation caused by nonphysiological hemodynamic shear stresses in these PHVs, very few systems attempt to characterize both blood damage and fluid dynamics aspects of PHVs in the same test system. Various numerical modeling methodologies are also evolving to simulate the structural mechanics, fluid mechanics, and blood damage aspects of these devices. This article presents a completely hemocompatible smallvolume testplatform that can be used for thrombogenicity studies and experimental fluid mechanics characterization. Using a programmable piston pump to drive freshly drawn human blood inside a cylindrical column, the presented system can simulate various physiological and pathophysiological conditions in testing PHVs. The system includes a modular devicemounting chamber, and in this presented case, a 23 mm St. Jude Medical (SJM) Regentsآ® mechanical heart valve (MHV) in aortic position was used as the test device. The system was validated for its capability to quantify blood damage by measuring blood damage induced by the tester itself (using freshly drawn whole human blood). Blood damage levels were ascertained through clinically relevant assays on human blood while fluid dynamics were characterized using timeresolved particle image velocimetry (PIV) using a bloodmimicking fluid. Blood damage induced by the tester itself, assessed through ThrombinantiThrombin (TAT), Prothrombin factor 1.2 (PF1.2), and hemolysis (Drabkins assay), was within clinically accepted levels. The hydrodynamic performance of the tester showed consistent, repeatable physiological pressure and flow conditions. In addition, the system contains proximity sensors to accurately capture leaflet motion during the entire cardiac cycle. The PIV results showed skewing of the leakage jet, caused by the asymmetric closing of the two leaflets. All these results are critical to characterizing the blood damage and fluid dynamics characteristics of the SJM Regentsآ® MHV, proving the utility of this tester as a precise system for assessing the hemodynamics and thrombogenicity for various PHVs.
publisherThe American Society of Mechanical Engineers (ASME)
titleDesign of a Pulsatile Flow Facility to Evaluate Thrombogenic Potential of Implantable Cardiac Devices
typeJournal Paper
journal volume137
journal issue4
journal titleJournal of Biomechanical Engineering
identifier doi10.1115/1.4029579
journal fristpage45001
journal lastpage45001
identifier eissn1528-8951
treeJournal of Biomechanical Engineering:;2015:;volume( 137 ):;issue: 004
contenttypeFulltext


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record